Henry J. Esber Ph.D.
Member of the Scientific Board of Advisors

Dr. Henry J. Esber is the Senior Vice President, Business Development of Primedica, a subsidiary of Genzyme, Inc. He is a member of the Scientific Advisory Board of Pro-Pharmaceuticals, Inc. Dr. Esber is co-founder of BioSignature Diagnostics, Inc. and Advanced Drug Delivery, Inc. In addition, he serves on the Scientific Advisory Board of several national and international biotechnology companies.

Dr. Esber has more than 25 years of experience in the areas of Oncology/Tumor Immunology and Immunotherapy as well as strong knowledge in the field of Toxicology and Regulatory Affairs all of which are extremely important in the drug development process. He has over 130 publications in various scientific journals and is a full member in various scientific societies and associations.

Dr. Esber earned a B.S. in Biology/Pre-Med (1961) from the College of William and Mary, an M.S. in Public Health and Parasitology (1963) from the University of North Carolina and a Ph.D. in Immunology/Microbiology (1967) from West Virginia University Medical Center. Since then, he has been very active in research and development in the field of Immunology and Oncology.